Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “United Therapeutics Corporation”

95 pharma patents match "United Therapeutics Corporation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 95
Index total 30,257
Page 1 / 4

Quick answer

This filtered view shows 95 pharmaceutical patents matching "United Therapeutics Corporation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

95 results for “United Therapeutics Corporation” · 30,257 patents in full index Clear search

  1. US 12357599

    Prodrugs of treprostinil

    United Therapeutics Corporation · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted
  2. US 12310992

    Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

    United Therapeutics Corporation · Granted May 27, 2025 · Expires May 22, 2045

    granted
  3. US 12274684

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    United Therapeutics Corporation · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted
  4. US 12173021

    Treprostinil prodrugs

    United Therapeutics Corporation · Granted Dec 24, 2024 · Expires Dec 19, 2044

    granted
  5. US 12168071

    Treprostinil derivatives and their use in pharmaceutical compositions

    United Therapeutics Corporation · Granted Dec 17, 2024 · Expires Dec 12, 2044

    granted
  6. US 12162853

    Synthesis of esuberaprost prodrugs

    United Therapeutics Corporation · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  7. US 12098116

    Crystalline prostacyclin (IP) receptor agonist and uses thereof

    United Therapeutics Corporation · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  8. US 12017989

    Controlled release pharmaceutical formulations

    United Therapeutics Corporation · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  9. US 11839631

    Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

    United Therapeutics Corporation · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  10. US 11839596

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    United Therapeutics Corporation · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  11. US 11826328

    Stable treprostinil prodrugs

    United Therapeutics Corporation · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  12. US 11826327

    Treatment for interstitial lung disease

    United Therapeutics Corporation · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  13. US 11793780

    Prodrugs of treprosiinil

    United Therapeutics Corporation · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  14. US 11723887

    Process to prepare treprostinil, the active ingredient in Remodulin®

    United Therapeutics Corporation · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  15. US 11672863

    Enhanced solubility drug-containing formulations

    United Therapeutics Corporation · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  16. US 11672775

    Treprostinil prodrugs

    United Therapeutics Corporation · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  17. US 11666602

    Treatment of pulmonary arterial hypertension with mesenchymal stem cells

    United Therapeutics Corporation · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  18. US 11634443

    Treprostinil prodrugs

    United Therapeutics Corporation · Granted Apr 25, 2023 · Expires Apr 20, 2043

    granted
  19. US 11571444

    Enhancement of MSC immunomodulatory properties by treprostinil

    United Therapeutics Corporation · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted
  20. US 11560363

    Synthesis of esuberaprost prodrugs

    United Therapeutics Corporation · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  21. US 11357782

    Treprostinil administration by inhalation

    United Therapeutics Corporation · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted
  22. US 11292758

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted
  23. US 11236035

    Salts of treprostinil

    United Therapeutics Corporation · Granted Feb 1, 2022 · Expires Jan 27, 2042

    granted
  24. US 11141393

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    United Therapeutics Corporation · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted